CClinicalTrials.gg
CompletedNCT03810885STRIVEUpdated Jul 12, 2019

SalT Reduction InterVEntion: Metabolic, Behavioral and Health Consequences of Reducing Salt in Bread

An interventional study of Bread with reduced salt content and Dietary advice in Salt Intake, sponsored by Bispebjerg Hospital. Completed at 1 site in Denmark. Open to participants aged 3 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-12.

Sponsored by Bispebjerg Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Feb 2018, registered Nov 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
316
Allocation
Randomized
Ages
3 Years to 69 Years
Sex
All
01

Study summary

The trial is conducted as a randomized controlled trial including children and adults recruited as families. The families are randomly allocated into three groups to investigate the effect of different salt reduction strategies in a period of 3-4 months. Families in the first intervention group are receiving salt reduced bread. Families in the second intervention group are receiving salt reduced bread in combination with dietary counselling to reduce salt and increase potassium intake. Families in the control group are receiving bread with a regular content of salt and no dietary counselling.

Read the detailed description

The trial is conducted as a randomized controlled trial including children and adults recruited as families. The families are randomly allocated into three groups to investigate the effect of different salt reduction strategies in a period of 3-4 months. Families in the first intervention group are receiving salt reduced bread. Families in the second intervention group are receiving salt reduced bread in combination with dietary counselling to reduce salt and increase potassium intake. Families in the control group are receiving bread with a regular content of salt and no dietary counselling.

Participants will be instructed to replace their usual consumption of bread by the bread products provided in the study. In all other respects, participants will be requested to live their lives as usual without changing any habits, except the families receiving dietary counselling. The participants will be unaware of the treatment groups and the salt content of the bread products will be blinded to the participants.

Families will attend a physical examination at baseline and at 3-4 months follow-up. The health examination includes anthropometrics, blood pressure measurements and blood samplings for analysis of glucose, lipid metabolism and hormone balance. Urine samples will be collected to investigate the sodium and potassium content. Furthermore salt-sensitivity and preference tests will be made. After both health examinations the families will collect three repeated 24-hour urine collections at home and fill in a 7 days dietary record.

After data collection, blood and urine samples will be analysed. Analyses from both baseline and follow-up are expected ultimo February 2019, whereby data cleaning and statistical analyses will be performed.

02

Conditions studied

  • Salt Intake

Keywords

  • 24hr urine collection
03

In context

Lead sponsor

Bispebjerg Hospital is the lead sponsor of 281 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants living with children
  • Adults 18-69 years
  • Children 3-17 years
  • Daily intake of bread

Exclusion criteria

Exclusion Criteria:

  • Diabetes
  • Cardiovascular disease
  • Antihypertensive treatment
  • Lipid-lowering treatment
  • Pregnancy
  • U-albumin > 300 mg/day
  • Celiac disease
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
316 participants (actual)

Study arms

  • Experimental
    Salt reduced bread

    Bread with reduced salt content

    Other: Bread with reduced salt content

  • Experimental
    Dietary advice and Salt reduced bread

    bread with reduced salt content, dietary advice

    Other: Bread with reduced salt content · Behavioral: Dietary advice

  • Placebo comparator
    Normal bread

    Bread with standard salt content

    Other: Bread with standard salt content

Interventions

  • OtherBread with reduced salt content

    Bread with gradually lowered salt content

  • BehavioralDietary advice

    Participants will receive information on how to lower salt and increase potassium intake

  • OtherBread with standard salt content

    Bread with normal salt content

06

What researchers measure

Primary outcomes

  1. Change from Baseline sodium level in 24 hour urine at 4 months

    Adults average of 3 repeated 24 hour urine, children a single 24hour urine collection; excluding urine first morning including urine of the following morning. Completeness evaluated in adults by Para-Amino-Benzoic-Acid (PABA).

    Time frame: Measurements at Baseline and at 4 month.

Secondary outcomes

  1. Change from Baseline potassium level in 24 hour urine at 4 months

    Adults average of 3 repeated 24 hour urine, children a single 24hour urine collection; excluding urine first morning including urine of the following morning.

    Time frame: Measurements at Baseline and at 4 month.

  2. Change from Baseline Systolic blood pressure at 4 months

    Systolic blood pressure measured at baseline and follow-up . Average of three measurements, with the participant sitting upright at rest.. Minimum 2 hours fasting.

    Time frame: Measurements at Baseline and at 4 month.

  3. Change from Baseline Diastolic blood pressure at 4 months

    Diastolic blood pressure measured at baseline and follow-up . Average of three measurements, with the participant sitting upright at rest.. Minimum 2 hours fasting.

    Time frame: Measurements at Baseline and at 4 month.

  4. Change from Baseline Adrenaline and Noradrenaline levels in plasma at 4 months

    blood sampled, stored on ice, with the participant lying down after 30 minutes of rest. Minimum 2 hours of fasting.

    Time frame: Measurements at Baseline and at 4 month.

  5. Change from Baseline Renin and Aldosterone levels in plasma at 4 months

    blood sampled, with the participant lying down after 30 minutes of rest. Minimum 2 hours of fasting.

    Time frame: Measurements at Baseline and at 4 month.

  6. Change from Baseline Salt sensitivity and preference at 4 months

    Sensory test: Sensitivity and preference test, minimum 2 hours of fasting

    Time frame: Measurements at Baseline and at 4 month.

Other outcomes

  1. Change from Baseline Glucose levels in plasma at 4 months

    blood sampled, with the participant lying down after 30 minutes of rest. Minimum 2 hours of fasting.

    Time frame: Measurements at Baseline and at 4 month.

  2. Change from Baseline HbA1C levels in full blood at 4 months

    blood sampled, with the participant lying down after 30 minutes of rest. Minimum 2 hours of fasting.

    Time frame: Measurements at Baseline and at 4 month.

  3. Change from Baseline Cholesterol levels in plasma (LDL, HDL, total cholesterol and triglycerides) at 4 months

    blood sampled, with the participant lying down after 30 minutes of rest. Minimum 2 hours of fasting.

    Time frame: Measurements at Baseline and at 4 month.

  4. Change from Baseline Height in centimetres at 4 months

    Measured in centimetres to the closest decimal, without shoes or socks, with clothes on

    Time frame: Measurements at Baseline and at 4 month.

  5. Change from Baseline Weight in kilograms at 4 months

    Measured in kilograms to the closest decimal, without shoes or socks, with clothes on

    Time frame: Measurements at Baseline and at 4 month.

  6. Change from Baseline Impedance in ohm at 4 months

    Measured in ohm to the closest decimal, without shoes or socks, with clothes on

    Time frame: Measurements at Baseline and at 4 month.

  7. Change from Baseline Hip circumference in centimetres at 4 months

    Measured on bare skin to nearest decimal

    Time frame: Measurements at Baseline and at 4 month.

  8. Change from Baseline Waist circumference in centimetres at 4 months

    Measured on bare skin to nearest decimal

    Time frame: Measurements at Baseline and at 4 month.

  9. Baseline Albumin in spot urine

    Not morning urine, minimum 2 hours of fasting

    Time frame: Measurements at Baseline

  10. Change from Baseline Sodium, potassium and creatinine level in spot urine at 4 months

    Not morning urine, minimum 2 hours of fasting

    Time frame: Measurements at Baseline and at 4 month.

07

Study locations

1 site
  • Center fot Clinical Research and Prevention
    Glostrup, Capital Region 2600, Denmark
08

References and documents

Study documents

  • Study protocol · Dec 22, 2017
  • Statistical analysis plan · Nov 30, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 12, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03810885
Lead sponsor
Bispebjerg Hospital
Responsible party
Ulla Toft (Associate Professor, PhD, MSc, Head of Section of Health Promotion and Prevention, Bispebjerg Hospital) — Principal investigator
First posted
Jan 22, 2019
Start date
Feb 1, 2018
Primary completion
Apr 30, 2019
Completion
Apr 30, 2019
Last update
Jul 12, 2019

Study contacts

Ulla Toft, MSc, PhD
principal investigator · Capital Region, Copenhagen, Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion